| P50 | author | Balik Dzhambazov | Q43169725 |
| | Tsvetelina Batsalova | Q59696138 |
| P2093 | author name string | Rikard Holmdahl | |
| | Anna Linusson | |
| | C David Andersson | |
| | Jan Kihlberg | |
| | Ida E Andersson | |
| P2860 | cites work | Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures | Q27622749 |
| | Structural and functional consequences of altering a peptide MHC anchor residue | Q27629883 |
| | Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1 | Q27641946 |
| | X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II | Q27746792 |
| | Gaussian docking functions | Q28208578 |
| | Comparison of consensus scoring strategies for evaluating computational models of protein-ligand complexes | Q28292827 |
| | The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis | Q28306666 |
| | A critical assessment of docking programs and scoring functions | Q29616761 |
| | Statistical molecular design of peptoid libraries | Q30643663 |
| | Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis | Q30878890 |
| | Improving structure-based virtual screening by multivariate analysis of scoring data | Q30885875 |
| | Detailed analysis of scoring functions for virtual screening | Q30985789 |
| | Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis | Q31089923 |
| | MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue | Q31144055 |
| | Multivariate design, synthesis, and biological evaluation of peptide inhibitors of FimC/FimH protein-protein interactions in uropathogenic Escherichia coli | Q31147826 |
| | Evaluation and application of multiple scoring functions for a virtual screening experiment | Q33209809 |
| | Quantitative structure-activity relationship of peptides binding to the class II major histocompatibility complex molecule Aq associated with autoimmune arthritis | Q33281660 |
| | Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4. | Q33291961 |
| | Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase. | Q33301699 |
| | Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice. | Q35605653 |
| | Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness | Q36009049 |
| | Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates | Q36345534 |
| | Consensus scoring for protein-ligand interactions | Q36458866 |
| | Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. | Q36498837 |
| | Modeling the structure of bound peptide ligands to major histocompatibility complex | Q36519420 |
| | Deciphering common failures in molecular docking of ligand-protein complexes. | Q38305525 |
| | Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151. | Q40450058 |
| | Identification of the minimal glycopeptide core recognized by T cells in a model for rheumatoid arthritis. | Q40480825 |
| | Radically altered T cell receptor signaling in glycopeptide-specific T cell hybridoma induced by antigen with minimal differences in the glycan group | Q40763215 |
| | Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules | Q40945287 |
| | Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis. | Q41005128 |
| | Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis | Q41173522 |
| | Modification of peptide interaction with MHC creates TCR partial agonists | Q42045156 |
| | T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk. | Q42086872 |
| | Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation | Q42963596 |
| | Oxazole-modified glycopeptides that target arthritis-associated class II MHC A(q) and DR4 proteins. | Q43058987 |
| | Glycopeptide specificity of helper T cells obtained in mouse models for rheumatoid arthritis | Q44237847 |
| | Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides. | Q45181052 |
| | Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55. | Q45213685 |
| | A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists | Q46121537 |
| | Ligand recognition by alpha beta T cell receptors | Q46222293 |
| | Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules | Q46902180 |
| | Probing molecular interactions within class II MHC Aq/glycopeptide/T-cell receptor complexes associated with collagen-induced arthritis | Q46943892 |
| | Structural mining: self-consistent design on flexible protein-peptide docking and transferable binding affinity potential | Q47239403 |
| | A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance | Q47307422 |
| | Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. | Q48028246 |
| | Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator. | Q50893484 |
| | Comparative performance assessment of the conformational model generators omega and catalyst: a large-scale survey on the retrieval of protein-bound ligand conformations. | Q51936967 |
| | Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. | Q52135209 |
| | Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. | Q53678858 |
| | The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses | Q56454402 |
| | PLS-regression: a basic tool of chemometrics | Q56454404 |
| | Principal component analysis | Q56763826 |
| | Analysis of key parameters for molecular dynamics of pMHC molecules | Q58616537 |
| | Immunisation against heterologous type II collagen induces arthritis in mice | Q59053172 |
| | A New Concept for Multidimensional Selection of Ligand Conformations (MultiSelect) and Multidimensional Scoring (MultiScore) of Protein−Ligand Binding Affinities | Q62648697 |
| | Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection | Q67539006 |
| | A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis | Q70682099 |
| | Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis | Q72049171 |
| | Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401 | Q72332685 |
| | The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules | Q74375742 |
| | High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling | Q77769114 |
| | Major histocompatibility complex class II binding characteristics of peptoid-peptide hybrids | Q77892128 |
| | Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice | Q78667423 |
| | Modeling ligand-receptor interaction for some MHC class II HLA-DR4 peptide mimetic inhibitors using several molecular docking and 3D QSAR techniques | Q81253747 |
| | Side-chain and backbone amide bond requirements for glycopeptide stimulation of T-cells obtained in a mouse model for rheumatoid arthritis | Q83953115 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | CII259-273 | Q27131830 |
| | Gly-Ile-Ala-Gly-Phe(4-F)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131831 |
| | Gly-Ile-Ala-Gly-Tyr-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131832 |
| | Gly-Ile-Ala-Gly-Ala(thiazol-4-yl)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131834 |
| | Gly-Hle-Ala-Gly-Phe(4-F)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131835 |
| | Gly-Hle-Ala-Gly-Cha-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131836 |
| | Gly-Hle-Ala-Gly-Ala(thiazol-4-yl)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131837 |
| | Gly-Cpa-Ala-Gly-Phe(3-Me)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131838 |
| | Gly-Cpa-Ala-Gly-Cha-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131839 |
| | Gly-Cpa-Ala-Gly-Ala(4-Py)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131840 |
| | Gly-Chg-Ala-Gly-Phe(3-Me)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131841 |
| | Gly-Chg-Ala-Gly-Tyr-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131842 |
| | Gly-Chg-Ala-Gly-Ala(4-Py)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131843 |
| | Gly-Ala(thiazol-4-yl)-Ala-Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131844 |
| | Gly-Ala(thiazol-4-yl)-Ala-Gly-Phe(3-Me)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131847 |
| | Gly-Ala(thiazol-4-yl)-Ala-Gly-Ala(4-Py)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131848 |
| | Gly-Gln-Ala-Gly-Ala(thiazol-4-yl)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131849 |
| | Gly-Gln-Ala-Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131850 |
| | Gly-Gln-Ala-Gly-Tyr-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131851 |
| | Gly-Aic-Ala-Gly-Cha-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131852 |
| | Gly-Aic-Ala-Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr | Q27131853 |
| P304 | page(s) | e17881 | |
| P577 | publication date | 2011-03-15 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Design of glycopeptides used to investigate class II MHC binding and T-cell responses associated with autoimmune arthritis | |
| P478 | volume | 6 | |